Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Site specific in vivo activation of therapeutic drugs

Site specific in vivo activation of therapeutic drugs

US Patent 5433955 · Granted Jul 18, 1995

Estimated economic value: $756,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

USB based cloud disk and disk segment management system2022
Induction of antigen-specific tolerance by peripheral phagocytosis2021
Controlled activation of complement components for use as endogenous adjuvant2019
Human complement C3 derivates with cobra venom factor-like function2014
Botulinum antitoxin compositions and methods2013
Complement depletion using recombinant human C-3 derivatives2012
Chimera of human IgE receptor α-chain and avian constant immuno-globulin domains2011
Backlight unit2010
Bivalent IgY antibody constructs for diagnostic and therapeutic applications2010
Sterile immunogenic non-tumorigenic tumor cell compositions and methods2009
Via hole having fine hole land and method for forming the same2009
Complement depletion using recombinant human C3-derivatives2009